Erratum: Histone demethylase KDM6B promotes epithelial-mesenchymal transition (Journal of Biological Chemistry (2012) 287 (44508 – 44517) DOI: 10.1074/jbc.M112.424903);Histone demethylase KDM6B promotes epithelial-mesenchymal transition

Journal of Biological Chemistry

Volumn 287, Issue 53, 2012, Pages 44508-44517

  Ramadoss, Sivakumar ^a   Chen, Xiaohong ^a   Wang, Cun Yu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; ALKYLATION; AMINO ACIDS; DISEASES; PATHOLOGY; TISSUE; TISSUE REGENERATION;

CHROMATIN IMMUNOPRECIPITATION ASSAY; CHROMATIN MODIFICATION; EMBRYONIC DEVELOPMENT; EPIGENETIC MECHANISMS; EPITHELIAL-MESENCHYMAL TRANSITION; HISTONE ACETYLATION; MAMMARY EPITHELIAL CELLS; MOLECULAR REGULATION;

GENE EXPRESSION;

CELL PROTEIN; HISTONE DEMETHYLASE; HISTONE H3 LYSINE; KDM6B PROTEIN; LYSINE; SNAI1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; CANCER INVASION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; HISTONE METHYLATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84871748359     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.AAC120.013773     Document Type: Erratum

References (48)

1. Thiery, J. P., Acloque, H., Huang, R. Y., and Nieto, M. A. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890
2. Singh, A., and Settleman, J. (2010) EMT, cancer stem cells and drug resistance. An emerging axis of evil in the war on cancer. Oncogene 29, 4741-4751
3. Thiery, J. P., and Sleeman, J. P. (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142 (Pubitemid 43278296)
4. Wendt, M. K., Tian, M., and Schiemann, W. P. (2012) Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression. Cell Tissue Res. 347, 85-101
5. Feng, X. H., and Derynck, R. (2005) Specificity and versatility in TGF-β signaling through Smads. Annu. Rev. Cell Dev. Biol. 21, 659-693
6. Massagué, J., and Gomis, R. R. (2006) The logic of TGF β signaling. FEBS Lett. 580, 2811-2820
7. Shi, Y., and Massagué, J. (2003) Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113, 685-700 (Pubitemid 36724933)
8. Yamane, K., Toumazou, C., Tsukada, Y., Erdjument-Bromage, H., Tempst, P., Wong, J., and Zhang, Y. (2006) JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125, 483-495
9. Dahle, Ø., Kumar, A., and Kuehn, M. R. (2010) Nodal signaling recruits the histone demethylase Jmjd3 to counteract polycomb-mediated repression at target genes. Sci. Signal. 3, ra48
10. Jenuwein, T., and Allis, C. D. (2001) Translating the histone code. Science 293, 1074-1080 (Pubitemid 32758077)
11. Kouzarides, T. (2007) Chromatin modifications and their function. Cell 128, 693-705
12. Lund, A. H., and van Lohuizen, M. (2004) Polycomb complexes and silencing mechanisms. Curr. Opin. Cell Biol. 16, 239-246 (Pubitemid 38610403)
13. Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., and Zhang, Y. (2003) Role of histone H3 lysine 27 methylation in X inactivation. Science 300, 131-135 (Pubitemid 36423045)
14. Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J., and Lee, J. T. (2008) Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750-756
15. Schuettengruber, B., and Cavalli, G. (2009) Recruitment of polycomb group complexes and their role in the dynamic regulation of cell fate choice. Development 136, 3531-3542
16. Agger, K., Cloos, P. A., Christensen, J., Pasini, D., Rose, S., Rappsilber, J., Issaeva, I., Canaani, E., Salcini, A. E., and Helin, K. (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449, 731-734 (Pubitemid 47552088)
17. De Santa, F., Totaro, M. G., Prosperini, E., Notarbartolo, S., Testa, G., and Natoli, G. (2007) The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130, 1083-1094 (Pubitemid 47410272)
18. Lan, F., Bayliss, P. E., Rinn, J. L., Whetstine, J. R., Wang, J. K., Chen, S., Iwase, S., Alpatov, R., Issaeva, I., Canaani, E., Roberts, T. M., Chang, H. Y., and Shi, Y. (2007) A histone H3 lysine 27 demethylase regulates animal posterior development. Nature 449, 689-694 (Pubitemid 47552096)
19. Swigut, T., and Wysocka, J. (2007) H3K27 demethylases, at long last. Cell 131, 29-32 (Pubitemid 47498542)
20. Hong, S., Cho, Y. W., Yu, L. R., Yu, H., Veenstra, T. D., and Ge, K. (2007) Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases. Proc. Natl. Acad. Sci. U.S.A. 104, 18439-18444 (Pubitemid 350210715)
21. Miller, S. A., Mohn, S. E., and Weinmann, A. S. (2010) Jmjd3 and UTX play a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression. Mol. Cell 40, 594-605
22. Hübner, M. R., and Spector, D. L. (2010) Role of H3K27 demethylases Jmjd3 and UTX in transcriptional regulation. Cold Spring Harb. Symp. Quant. Biol. 75, 43-49
23. Agger, K., Cloos, P. A., Rudkjaer, L., Williams, K., Andersen, G., Christensen, J., and Helin, K. (2009) The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev. 23, 1171-1176
24. Barradas, M., Anderton, E., Acosta, J. C., Li, S., Banito, A., Rodriguez-Niedenführ, M., Maertens, G., Banck, M., Zhou, M. M., Walsh, M. J., Peters, G., and Gil, J. (2009) Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev. 23, 1177-1182
25. Kim, S. W., Yoon, S. J., Chuong, E., Oyolu, C., Wills, A. E., Gupta, R., and Baker, J. (2011) Chromatin and transcriptional signatures for Nodal signaling during endoderm formation in hESCs. Dev. Biol. 357, 492-504
26. Ramadoss, S., Li, J., Ding, X., Al Hezaimi, K., and Wang, C. Y. (2011) Transducin β-like protein 1 recruits nuclear factor κB to the target gene promoter for transcriptional activation. Mol. Cell Biol. 31, 924-934
27. Sen, G. L., Webster, D. E., Barragan, D. I., Chang, H. Y., and Khavari, P. A. (2008) Control of differentiation in a self-renewing mammalian tissue by the histone demethylase JMJD3. Genes Dev. 22, 1865-1870 (Pubitemid 352008635)
28. Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., Hallett, M., and Park, M. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14, 518-527 (Pubitemid 351655218)
29. Radvanyi, L., Singh-Sandhu, D., Gallichan, S., Lovitt, C., Pedyczak, A., Mallo, G., Gish, K., Kwok, K., Hanna, W., Zubovits, J., Armes, J., Venter, D., Hakimi, J., Shortreed, J., Donovan, M., Parrington, M., Dunn, P., Oomen, R., Tartaglia, J., and Berinstein, N. L. (2005) The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancer. Proc. Natl. Acad. Sci. U.S.A. 102, 11005-11010 (Pubitemid 41105983)
30. Sivakumar, R., Koga, H., Selvendiran, K., Maeyama, M., Ueno, T., and Sata, M. (2009) Autocrine loop for IGF-I receptor signaling in SLUG-mediated epithelial-mesenchymal transition. Int. J. Oncol. 34, 329-338
31. De Santa, F., Narang, V., Yap, Z. H., Tusi, B. K., Burgold, T., Austenaa, L., Bucci, G., Caganova, M., Notarbartolo, S., Casola, S., Testa, G., Sung, W. K., Wei, C. L., and Natoli, G. (2009) Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 28, 3341-3352
32. Smith, A. P., Verrecchia, A., Fagà, G., Doni, M., Perna, D., Martinato, F., Guccione, E., and Amati, B. (2009) A positive role for Myc in TGF-β-induced Snai1 transcription and epithelial-to-mesenchymal transition. Oncogene 28, 422-430
33. May, C. D., Sphyris, N., Evans, K. W., Werden, S. J., Guo, W., and Mani, S. A. (2011) Epithelial-mesenchymal transition and cancer stem cells. A dangerously dynamic duo in breast cancer progression. Breast Cancer Res. 13, 202
34. Vega, S., Morales, A. V., Ocaña, O. H., Valdés, F., Fabregat, I., and Nieto, M. A. (2004) Snai1 blocks the cell cycle and confers resistance to cell death. Genes Dev. 18, 1131-1143 (Pubitemid 38669034)
35. Olmeda, D., Jordá, M., Peinado, H., Fabra, A., and Cano, A. (2007) Snai1 silencing effectively suppresses tumour growth and invasiveness. Oncogene 26, 1862-1874 (Pubitemid 46474642)
36. Kajita, M., McClinic, K. N., and Wade, P. A. (2004) Aberrant expression of the transcription factors snai1 and slug alters the response to genotoxic stress. Mol. Cell Biol. 24, 7559-7566 (Pubitemid 39121483)
37. Xiang, Y., Zhu, Z., Han, G., Lin, H., Xu, L., and Chen, C. D. (2007) JMJD3 is a histone H3K27 demethylase. Cell Res. 17, 850-857 (Pubitemid 47585113)
38. Anderton, J. A., Bose, S., Vockerodt, M., Vrzalikova, K., Wei, W., Kuo, M., Helin, K., Christensen, J., Rowe, M., Murray, P. G., and Woodman, C. B. (2011) The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's lymphoma. Oncogene 30, 2037-2043
39. Pereira, F., Barbáchano, A., Silva, J., Bonilla, F., Campbell, M. J., Muñoz, A., and Larriba, M. J. (2011) KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum. Mol. Genet. 20, 4655-4665
40. Kunju, L. P., Cookingham, C., Toy, K. A., Chen, W., Sabel, M. S., and Kleer, C. G. (2011) EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development. Mod. Pathol. 24, 786-793
41. Gong, Y., Huo, L., Liu, P., Sneige, N., Sun, X., Ueno, N. T., Lucci, A., Buchholz, T. A., Valero, V., and Cristofanilli, M. (2011) Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome. Cancer 117, 5476-5484
42. Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G., Otte, A. P., Hayes, D. F., Sabel, M. S., Livant, D., Weiss, S. J., Rubin, M. A., and Chinnaiyan, A. M. (2003) EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 100, 11606-11611 (Pubitemid 37205983)
43. Ding, L., Erdmann, C., Chinnaiyan, A. M., Merajver, S. D., and Kleer C. G. (2006) Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues. Cancer Res. 66, 4095-4099
44. Kowalski, P. J., Rubin, M. A., and Kleer, C. G. (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res. 5, 217-222
45. Chao, Y. L., Shepard, C. R., Wells, A. (2010) Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol. Cancer 9, 179
46. Chaffer, C. L., Thompson, E. W., and Williams, E. D. (2007) Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 185, 7-19 (Pubitemid 46956838)
47. Hugo, H., Ackland, M. L., Blick, T., Lawrence, M. G., Clements, J. A., Williams, E. D., and Thompson, E. W. (2007) Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J. Cell Physiol. 213, 374-383 (Pubitemid 47509716)
48. Thiery, J. P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442-454